The DOI matches its Crossref record.
A computational procedure for determining energetically favorable binding sites on biologically important macromolecules
Abstract
The interaction of a probe group with a protein of known structure is computed at sample positions throughout and around the macromolecule, giving an array of energy values. The probes include water, the methyl group, amine nitrogen, carboxy oxygen, and hydroxyl. Contour surfaces at appropriate energy levels are calculated for each probe and displayed by computer graphics together with the protein structure. Contours at negative energy levels delineate contours also enable other regions of attraction between probe and protein and are found at known ligand binding clefts in particular. The contours also enable other regions of attraction to be identified and facilitate the interpretation of protein-ligand energetics. They may, therefore, be of value for drug design.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Molecular Docking: A Powerful Approach for Structure-Based Drug Discovery
Meng, X.-Y., Zhang, H.-X., Mezei, M., & Cui, M. (2011) · Current Computer Aided-Drug Design · doi:10.2174/157340911795677602 · Cited by 3,771
A semiempirical free energy force field with charge‐based desolvation
Huey, R., Morris, G. M., Olson, A. J., & Goodsell, D. S. (2007) · Journal of Computational Chemistry · doi:10.1002/jcc.20634 · Cited by 2,246
QSAR Modeling: Where have you been? Where are you going to?
Cherkasov, A., Muratov, E. N., Fourches, D., Varnek, A., Baskin, I. I., Cronin, M., Dearden, J., Gramatica, P., Martin, Y. C., Todeschini, R., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm4004285 · Cited by 2,164
Rational design of potent sialidase-based inhibitors of influenza virus replication
von Itzstein, M., Wu, W.-Y., Kok, G. B., Pegg, M. S., Dyason, J. C., Jin, B., Van Phan, T., Smythe, M. L., White, H. F., Oliver, S. W., et al. (1993) · Nature · doi:10.1038/363418a0 · Cited by 1,862
Identifying and Characterizing Binding Sites and Assessing Druggability
Halgren, T. A. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci800324m · Cited by 1,759
Software for molecular docking: a review
Pagadala, N. S., Syed, K., & Tuszynski, J. (2017) · Biophysical Reviews · doi:10.1007/s12551-016-0247-1 · Cited by 1,522
Principles of docking: An overview of search algorithms and a guide to scoring functions
Halperin, I., Ma, B., Wolfson, H., & Nussinov, R. (2002) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.10115 · Cited by 1,294
Understanding enzyme immobilisation
Hanefeld, U., Gardossi, L., & Magner, E. (2009) · Chem. Soc. Rev. · doi:10.1039/b711564b · Cited by 1,237
Q-SiteFinder: an energy-based method for the prediction of protein-ligand binding sites
Laurie, A. T. R., & Jackson, R. M. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti315 · Cited by 1,047
Distributed automated docking of flexible ligands to proteins: Parallel applications of AutoDock 2.4
Morris, G. M., Goodsell, D. S., Huey, R., & Olson, A. J. (1996) · Journal of Computer-Aided Molecular Design · doi:10.1007/bf00124499 · Cited by 1,042
Walters, W. P., Stahl, M. T., & Murcko, M. A. (1998) · Drug Discovery Today · doi:10.1016/s1359-6446(97)01163-x · Cited by 991
Structure-Based Strategies for Drug Design and Discovery
Kuntz, I. D. (1992) · Science · doi:10.1126/science.257.5073.1078 · Cited by 989
Machine learning in chemoinformatics and drug discovery
Lo, Y.-C., Rensi, S. E., Torng, W., & Altman, R. B. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.05.010 · Cited by 960
The Process of Structure-Based Drug Design
Anderson, A. C. (2003) · Chemistry & Biology · doi:10.1016/j.chembiol.2003.09.002 · Cited by 939
Automated docking with grid‐based energy evaluation
Meng, E. C., Shoichet, B. K., & Kuntz, I. D. (1992) · Journal of Computational Chemistry · doi:10.1002/jcc.540130412 · Cited by 938
A View of the Hydrophobic Effect
Southall, N. T., Dill, K. A., & Haymet, A. D. J. (2002) · The Journal of Physical Chemistry B · doi:10.1021/jp015514e · Cited by 913
Molecular Recognition of Protein−Ligand Complexes: Applications to Drug Design
Babine, R. E., & Bender, S. L. (1997) · Chemical Reviews · doi:10.1021/cr960370z · Cited by 892
The computer program LUDI: A new method for the de novo design of enzyme inhibitors
B�hm, H.-J. (1992) · Journal of Computer-Aided Molecular Design · doi:10.1007/bf00124387 · Cited by 835
DOCK 6: Impact of new features and current docking performance
Allen, W. J., Balius, T. E., Mukherjee, S., Brozell, S. R., Moustakas, D. T., Lang, P. T., Case, D. A., Kuntz, I. D., & Rizzo, R. C. (2015) · Journal of Computational Chemistry · doi:10.1002/jcc.23905 · Cited by 833
Virtual and biomolecular screening converge on a selective agonist for GPR30
Bologa, C. G., Revankar, C. M., Young, S. M., Edwards, B. S., Arterburn, J. B., Kiselyov, A. S., Parker, M. A., Tkachenko, S. E., Savchuck, N. P., Sklar, L. A., et al. (2006) · Nature Chemical Biology · doi:10.1038/nchembio775 · Cited by 818
Molecular Recognition and Docking Algorithms
Brooijmans, N., & Kuntz, I. D. (2003) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.32.110601.142532 · Cited by 788
Combining docking and molecular dynamic simulations in drug design
Alonso, H., Bliznyuk, A. A., & Gready, J. E. (2006) · Medicinal Research Reviews · doi:10.1002/med.20067 · Cited by 759
Molecular fields in quantitative structure–permeation relationships: the VolSurf approach
Cruciani, G., Crivori, P., Carrupt, P.-A., & Testa, B. (2000) · Journal of Molecular Structure: THEOCHEM · doi:10.1016/s0166-1280(99)00360-7 · Cited by 566
Predicting drug metabolism: experiment and/or computation?
Kirchmair, J., Göller, A. H., Lang, D., Kunze, J., Testa, B., Wilson, I. D., Glen, R. C., & Schneider, G. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4581 · Cited by 502
Brenke, R., Kozakov, D., Chuang, G.-Y., Beglov, D., Hall, D., Landon, M. R., Mattos, C., & Vajda, S. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp036 · Cited by 455
Molecular docking using shape descriptors
Shoichet, B. K., Kuntz, I. D., & Bodian, D. L. (1992) · Journal of Computational Chemistry · doi:10.1002/jcc.540130311 · Cited by 425
VolSurf: a new tool for the pharmacokinetic optimization of lead compounds
Cruciani, G., Pastor, M., & Guba, W. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00162-7 · Cited by 419
A role for surface hydrophobicity in protein‐protein recognition
Young, L., Jernigan, R. L., & Covell, D. G. (1994) · Protein Science · doi:10.1002/pro.5560030501 · Cited by 391
Modeling water molecules in protein-ligand docking using GOLD.
Verdonk, M. L., Chessari, G., Cole, J. C., Hartshorn, M. J., Murray, C. W., Nissink, J. W. M., Taylor, R. D., & Taylor, R. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050543p · Cited by 393
Drug Design by Pharmacophore and Virtual Screening Approach
Giordano, D., Biancaniello, C., Argenio, M. A., & Facchiano, A. (2022) · Pharmaceuticals · doi:10.3390/ph15050646 · Cited by 384
Baroni, M., Costantino, G., Cruciani, G., Riganelli, D., Valigi, R., & Clementi, S. (1993) · Quantitative Structure-Activity Relationships · doi:10.1002/qsar.19930120103 · Cited by 375
Lüdemann, S. K., Lounnas, V., & Wade, R. C. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.4154 · Cited by 326
Predicting protein druggability
Hajduk, P. J., Huth, J. R., & Tse, C. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03624-x · Cited by 289
Recanatini, M., Poluzzi, E., Masetti, M., Cavalli, A., & De Ponti, F. (2005) · Medicinal Research Reviews · doi:10.1002/med.20019 · Cited by 285
Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery
Pérot, S., Sperandio, O., Miteva, M. A., Camproux, A.-C., & Villoutreix, B. O. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.05.015 · Cited by 276
Frödin, M., Antal, T. L., Dümmler, B. A., Jensen, C. J., Deak, M., Gammeltoft, S., & Biondi, R. M. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf551 · Cited by 275
Identification of Protein–Protein Interaction Sites from Docking Energy Landscapes
Fernández-Recio, J., Totrov, M., & Abagyan, R. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.10.069 · Cited by 274
Progress in predicting human ADME parameters in silico
Ekins, S., Waller, C. L., Swaan, P. W., Cruciani, G., Wrighton, S. A., & Wikel, J. H. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00109-x · Cited by 274
Next generation 3D pharmacophore modeling
Schaller, D., Šribar, D., Noonan, T., Deng, L., Nguyen, T. N., Pach, S., Machalz, D., Bermudez, M., & Wolber, G. (2020) · WIREs Computational Molecular Science · doi:10.1002/wcms.1468 · Cited by 269
Developing a Dynamic Pharmacophore Model for HIV-1 Integrase
Carlson, H. A., Masukawa, K. M., Rubins, K., Bushman, F. D., Jorgensen, W. L., Lins, R. D., Briggs, J. M., & McCammon, J. A. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990322h · Cited by 259
Fragment-Based Lead Discovery and Design
Joseph-McCarthy, D., Campbell, A. J., Kern, G., & Moustakas, D. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci400731w · Cited by 129
Modeling the structure of the StART domains of MLN64 and StAR proteins in complex with cholesterol
Murcia, M., Faráldo-Gómez, J. D., Maxfield, F. R., & Roux, B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600232-jlr200 · Cited by 111
An automated PLS search for biologically relevant QSAR descriptors
Olah, M., Bologa, C., & Oprea, T. I. (2004) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-004-4060-8 · Cited by 91
Xu, M., Ran, T., & Chen, H. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c01494 · Cited by 85
Fragment Informatics and Computational Fragment‐Based Drug Design: An Overview and Update
Sheng, C., & Zhang, W. (2013) · Medicinal Research Reviews · doi:10.1002/med.21255 · Cited by 80
Water, water, everywhere… It’s time to stop and think.
Bodnarchuk, M. S. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.05.009 · Cited by 81
Pharmacokinetically Based Mapping Device for Chemical Space Navigation
Oprea, T. I., Zamora, I., & Ungell, A.-L. (2002) · Journal of Combinatorial Chemistry · doi:10.1021/cc010093w · Cited by 77
Subnanomolar Inhibitors from Computer Screening: A Model Study Using Human Carbonic Anhydrase II
Grüneberg, S., Wendt, B., & Klebe, G. (2001) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20010119)40:2<389::aid-anie389>3.0.co;2-# · Cited by 76
Forli, S., & Botta, M. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci700036j · Cited by 58
Sako, M., Yasuo, N., & Sekijima, M. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c01385 · Cited by 21
Nordquist, E. B., Zhao, M., Kumar, A., & MacKerell, A. D. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c01189 · Cited by 15
Molecular Recognition in Biology: Models for Analysis of Protein—Ligand Interactions
Lancet, D., Horovitz, A., & Katchalski‐Katzir, E. (1994) · Perspectives in Supramolecular Chemistry · doi:10.1002/9780470511411.ch2 · Cited by 14
ILP-assisted de novo drug design
Kaalia, R., Srinivasan, A., Kumar, A., & Ghosh, I. (2016) · Machine Learning · doi:10.1007/s10994-016-5556-x · Cited by 13
The Basis for Target‐Based Virtual Screening: Protein Structures
Cole, J. C., Korb, O., Olsson, T. S. G., & Liebeschuetz, J. (2011) · Methods and principles in medicinal chemistry · doi:10.1002/9783527633326.ch4 · Cited by 9
Metadata
- Authors
- Goodford, P. J.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 849-857
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2080653934
- Cited by
- 2,634
- References
- 0
- FWCI
- 10.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.